Manuel Castro Cabezas
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 43
-
- Lipid metabolism and disorders 26
- Cardiovascular Disease and Adiposity 12
- Cardiovascular Function and Risk Factors 11
- Physiology top 2%
- Epidemiology top 2%
- Adipokines, Inflammation, and Metabolic Diseases 23
- Liver Disease Diagnosis and Treatment 23
- Biochemistry top 5%
-
- Lipoproteins and Cardiovascular Health 21
-
- Atherosclerosis and Cardiovascular Diseases 12
- Co-authors
- Boudewijn KlopTon J. RabelinkJ.P.H. van WijkA.J.H.H.M. van OostromEelco J.P. de KoningTjeerd SijmonsmaC. VerseydenD.W. Erkelens
- Journals
- Atherosclerosis (13 papers)European Journal of Clinical Investigation (12 papers)The Journal of Clinical Endocrinology & Metabolism (6 papers)
- Partner nations
- NetherlandsSpainAustralia
In The Last Decade
Manuel Castro Cabezas
146 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Endocrinology, Diabetes and Metabolism 1.6k
- Cardiology and Cardiovascular Medicine 1.2k
- Physiology 1.2k
- Epidemiology 1.2k
- Biochemistry 182
Countries citing papers authored by Manuel Castro Cabezas
This map shows the geographic impact of Manuel Castro Cabezas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Castro Cabezas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Castro Cabezas more than expected).
Fields of papers citing papers by Manuel Castro Cabezas
This network shows the impact of papers produced by Manuel Castro Cabezas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Castro Cabezas. The network helps show where Manuel Castro Cabezas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Manuel Castro Cabezas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2021 | 2 | |
| 4 | 2021 | 6 | |
| 5 | 2020 | 10 | |
| 6 | 2019 | 21 | |
| 7 | 2019 | 21 | |
| 8 | 2018 | 14 | |
| 9 | 2018 | 8 | |
| 10 | 2017 | 36 | |
| 11 | 2014 | 19 | |
| 12 | 2013 | 123 | |
| 13 | 2012 | 75 | |
| 14 | 2011 | 17 | |
| 15 | 2011 | 39 | |
| 16 | 2009 | 30 | |
| 17 | Reduced fecal sterol excretion in subjects with low HDL cholesterol levels | 2007 | 5 |
| 18 | 2006 | 35 | |
| 19 | 2006 | 89 | |
| 20 | 2003 | 52 |
About Manuel Castro Cabezas
Manuel Castro Cabezas is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Epidemiology, having authored 150 papers that have together received 5.1k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (43 papers), Lipid metabolism and disorders (26 papers), Adipokines, Inflammation, and Metabolic Diseases (23 papers), Liver Disease Diagnosis and Treatment (23 papers), Lipoproteins and Cardiovascular Health (21 papers), Atherosclerosis and Cardiovascular Diseases (12 papers), Cardiovascular Disease and Adiposity (12 papers) and Cardiovascular Function and Risk Factors (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.6k citations), Cardiology and Cardiovascular Medicine (1.2k citations) and Physiology (1.2k citations). Manuel Castro Cabezas has collaborated with scholars based in Netherlands, Spain and Australia. Frequent co-authors include Boudewijn Klop, Ton J. Rabelink, J.P.H. van Wijk, A.J.H.H.M. van Oostrom, Eelco J.P. de Koning, Tjeerd Sijmonsma, C. Verseyden, D.W. Erkelens, Arash Alipour and Erwin Birnie. Their work appears in journals such as Atherosclerosis, European Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism, Obesity Surgery and Atherosclerosis Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.